Kresge Eye Institute, Wayne State University, Detroit, Michigan 48201, USA.
Invest Ophthalmol Vis Sci. 2011 Nov 7;52(12):8739-46. doi: 10.1167/iovs.11-8045.
Mitochondrial function is controlled by membrane structure. In diabetes, retinal mitochondria are dysfunctional, and reversal of hyperglycemia fails to inhibit such changes. The goal of this study was to use anatomic and molecular biologic techniques to investigate the effect of diabetes on mitochondrial membrane structure.
Wistar rats were maintained in poor glycemic control (PC; GHb 11.2%) or good glycemic control (GC; GHb 5.5%) for 12 months or in PC for 6 months, followed by GC for an additional 6 months. The structure of the retinal mitochondria in the microvascular region was evaluated by electron microscopy (TEM) and gene expressions of mitochondrial structure-related proteins by rat mitochondrial PCR array. Representative genes were validated by real-time PCR, and their protein expression by Western blot. The results were confirmed in the retina obtained from human donors with diabetic retinopathy.
TEM showed enlarged mitochondria with partial cristolysis in the retinal microvasculature from PC rats, compared with those from normal rats. Among 84 genes, 6 retinal genes were upregulated and 12 were downregulated. PCR confirmed alternations in the gene expressions of fusion (Mfn2), carrier (Timm44 and Slc25a21), Akt1, and fission proteins (Dnm1l). Protein levels of Mfn2 and Dnm1l were consistent with their mRNA levels, but their mitochondrial abundance was decreased. Reversal of hyperglycemia failed to normalize these changes. Retinas from donors with diabetic retinopathy also presented similar patterns of changes in the gene and protein expressions.
Mitochondrial structural and transport proteins play an important role in the development of diabetic retinopathy and also in the metabolic memory phenomenon associated with its continued progression.
线粒体功能受膜结构控制。在糖尿病中,视网膜线粒体功能失调,逆转高血糖并不能抑制这些变化。本研究的目的是使用解剖学和分子生物学技术研究糖尿病对线粒体膜结构的影响。
Wistar 大鼠分别维持在血糖控制不良(PC;GHb11.2%)或良好(GC;GHb5.5%)12 个月,或 PC 6 个月后再 GC6 个月。通过电子显微镜(TEM)评估微血管区视网膜线粒体的结构,并通过大鼠线粒体 PCR 阵列评估与线粒体结构相关蛋白的基因表达。通过实时 PCR 验证代表性基因,并通过 Western blot 验证其蛋白表达。在患有糖尿病视网膜病变的人类供体的视网膜中证实了这些结果。
TEM 显示 PC 大鼠视网膜微血管中的线粒体增大,部分嵴溶解,与正常大鼠相比。在 84 个基因中,有 6 个视网膜基因上调,12 个基因下调。PCR 证实融合(Mfn2)、载体(Timm44 和 Slc25a21)、Akt1 和分裂蛋白(Dnm1l)的基因表达发生改变。Mfn2 和 Dnm1l 的蛋白水平与其 mRNA 水平一致,但它们的线粒体丰度降低。逆转高血糖并不能使这些变化正常化。糖尿病视网膜病变供体的视网膜也表现出类似的基因和蛋白表达变化模式。
线粒体结构和转运蛋白在糖尿病性视网膜病变的发生发展中以及与持续进展相关的代谢记忆现象中起着重要作用。